Emergence profiles of remimazolam-flumazenil versus propofol in pediatric general anesthesia for strabismus correction: a randomized clinical trial
Abstract Background Remimazolam (Rm) is a novel ultra-short-acting benzodiazepine used in general anesthesia. However, its application in pediatric general anesthesia remains limited. This study aims to compare the efficacy, safety, and postoperative emergence profiles of remimazolam and propofol (P...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Anesthesiology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12871-025-03050-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850042625623588864 |
|---|---|
| author | Jinling Qin Wei Gan Qun Liu Xiaolin Zhang Xiaoyu Li Bo Lu Qing Shen |
| author_facet | Jinling Qin Wei Gan Qun Liu Xiaolin Zhang Xiaoyu Li Bo Lu Qing Shen |
| author_sort | Jinling Qin |
| collection | DOAJ |
| description | Abstract Background Remimazolam (Rm) is a novel ultra-short-acting benzodiazepine used in general anesthesia. However, its application in pediatric general anesthesia remains limited. This study aims to compare the efficacy, safety, and postoperative emergence profiles of remimazolam and propofol (Pf) in pediatric surgical anesthesia. Methods Children (aged 3–12 years) undergoing strabismus correction surgery were randomly assigned to the Group Rm or the Group Pf. The Group Rm and Group Pf received an induction dose of 0.3 mg/kg and 2 mg/kg, respectively. For emergence, the Group Rm was administered flumazenil 0.2–0.3 mg. The primary outcome was the time from the discontinuation of anesthetic agents to the first eye opening. Secondary outcomes included the time from the end of surgery to laryngeal mask airway (LMA) removal, the time to achieve a Modified Observer’s Assessment of Alertness/Sedation (MOAA/S) score of 5 after LMA removal, and Aldrete scores during the postanesthetic care unit (PACU) stay. Additionally, the changes of vital signs before and after anesthesia were compared between the two groups. Results In all patients, both remimazolam and propofol induced anesthesia successfully. Regarding emergence profiles, the Group Rm had significantly shorter times to first eye opening, LMA removal, and achieving an MOAA/S score of 5 post-LMA removal compared to the Group Pf (p < 0.001). Upon arrival at the PACU, the number of patients with Aldrete scores ≥ 9 was significantly higher in the Group Rm (p < 0.001). Following injection, the reduction in DBP was significantly greater in the Group Pf compared to the Group Rm (p < 0.001). The Group Rm maintained a more stable HR compared to the Group Pf. Conclusion Remimazolam provides more stable hemodynamic characteristics and significantly shorter postoperative emergence time in pediatric patients compared to propofol. This suggests that remimazolam may be more suitable than propofol for pediatric general anesthesia, though larger scale clinical trials are needed for further validation. Trial registration : Chinese Clinical Trial Registry, ChiCTR2400083265. |
| format | Article |
| id | doaj-art-9e2fd631dff445f4b195fb46e142aafe |
| institution | DOAJ |
| issn | 1471-2253 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Anesthesiology |
| spelling | doaj-art-9e2fd631dff445f4b195fb46e142aafe2025-08-20T02:55:29ZengBMCBMC Anesthesiology1471-22532025-04-012511910.1186/s12871-025-03050-wEmergence profiles of remimazolam-flumazenil versus propofol in pediatric general anesthesia for strabismus correction: a randomized clinical trialJinling Qin0Wei Gan1Qun Liu2Xiaolin Zhang3Xiaoyu Li4Bo Lu5Qing Shen6Department of AnesthesiologyDepartment of Anesthesiology, Ningbo Aier Guangming Eye HospitalDepartment of Anesthesiology, Ningbo Aier Guangming Eye HospitalDepartment of Anesthesiology, Ningbo Aier Guangming Eye HospitalDepartment of AnesthesiologyDepartment of AnesthesiologyDepartment of AnesthesiologyAbstract Background Remimazolam (Rm) is a novel ultra-short-acting benzodiazepine used in general anesthesia. However, its application in pediatric general anesthesia remains limited. This study aims to compare the efficacy, safety, and postoperative emergence profiles of remimazolam and propofol (Pf) in pediatric surgical anesthesia. Methods Children (aged 3–12 years) undergoing strabismus correction surgery were randomly assigned to the Group Rm or the Group Pf. The Group Rm and Group Pf received an induction dose of 0.3 mg/kg and 2 mg/kg, respectively. For emergence, the Group Rm was administered flumazenil 0.2–0.3 mg. The primary outcome was the time from the discontinuation of anesthetic agents to the first eye opening. Secondary outcomes included the time from the end of surgery to laryngeal mask airway (LMA) removal, the time to achieve a Modified Observer’s Assessment of Alertness/Sedation (MOAA/S) score of 5 after LMA removal, and Aldrete scores during the postanesthetic care unit (PACU) stay. Additionally, the changes of vital signs before and after anesthesia were compared between the two groups. Results In all patients, both remimazolam and propofol induced anesthesia successfully. Regarding emergence profiles, the Group Rm had significantly shorter times to first eye opening, LMA removal, and achieving an MOAA/S score of 5 post-LMA removal compared to the Group Pf (p < 0.001). Upon arrival at the PACU, the number of patients with Aldrete scores ≥ 9 was significantly higher in the Group Rm (p < 0.001). Following injection, the reduction in DBP was significantly greater in the Group Pf compared to the Group Rm (p < 0.001). The Group Rm maintained a more stable HR compared to the Group Pf. Conclusion Remimazolam provides more stable hemodynamic characteristics and significantly shorter postoperative emergence time in pediatric patients compared to propofol. This suggests that remimazolam may be more suitable than propofol for pediatric general anesthesia, though larger scale clinical trials are needed for further validation. Trial registration : Chinese Clinical Trial Registry, ChiCTR2400083265.https://doi.org/10.1186/s12871-025-03050-wRemimazolamPropofolPediatric anesthesiaEmergence profilesHemodynamics |
| spellingShingle | Jinling Qin Wei Gan Qun Liu Xiaolin Zhang Xiaoyu Li Bo Lu Qing Shen Emergence profiles of remimazolam-flumazenil versus propofol in pediatric general anesthesia for strabismus correction: a randomized clinical trial BMC Anesthesiology Remimazolam Propofol Pediatric anesthesia Emergence profiles Hemodynamics |
| title | Emergence profiles of remimazolam-flumazenil versus propofol in pediatric general anesthesia for strabismus correction: a randomized clinical trial |
| title_full | Emergence profiles of remimazolam-flumazenil versus propofol in pediatric general anesthesia for strabismus correction: a randomized clinical trial |
| title_fullStr | Emergence profiles of remimazolam-flumazenil versus propofol in pediatric general anesthesia for strabismus correction: a randomized clinical trial |
| title_full_unstemmed | Emergence profiles of remimazolam-flumazenil versus propofol in pediatric general anesthesia for strabismus correction: a randomized clinical trial |
| title_short | Emergence profiles of remimazolam-flumazenil versus propofol in pediatric general anesthesia for strabismus correction: a randomized clinical trial |
| title_sort | emergence profiles of remimazolam flumazenil versus propofol in pediatric general anesthesia for strabismus correction a randomized clinical trial |
| topic | Remimazolam Propofol Pediatric anesthesia Emergence profiles Hemodynamics |
| url | https://doi.org/10.1186/s12871-025-03050-w |
| work_keys_str_mv | AT jinlingqin emergenceprofilesofremimazolamflumazenilversuspropofolinpediatricgeneralanesthesiaforstrabismuscorrectionarandomizedclinicaltrial AT weigan emergenceprofilesofremimazolamflumazenilversuspropofolinpediatricgeneralanesthesiaforstrabismuscorrectionarandomizedclinicaltrial AT qunliu emergenceprofilesofremimazolamflumazenilversuspropofolinpediatricgeneralanesthesiaforstrabismuscorrectionarandomizedclinicaltrial AT xiaolinzhang emergenceprofilesofremimazolamflumazenilversuspropofolinpediatricgeneralanesthesiaforstrabismuscorrectionarandomizedclinicaltrial AT xiaoyuli emergenceprofilesofremimazolamflumazenilversuspropofolinpediatricgeneralanesthesiaforstrabismuscorrectionarandomizedclinicaltrial AT bolu emergenceprofilesofremimazolamflumazenilversuspropofolinpediatricgeneralanesthesiaforstrabismuscorrectionarandomizedclinicaltrial AT qingshen emergenceprofilesofremimazolamflumazenilversuspropofolinpediatricgeneralanesthesiaforstrabismuscorrectionarandomizedclinicaltrial |